Preexisting and de novo humoral immunity to SARS-CoV-2 in humans
인간의 SARS-CoV-2에 대한 기존 및 새로운 체액 면역
Report
[키워드] acute respiratory syndrome
acute respiratory syndrome coronavirus
acute respiratory syndrome coronavirus 2
Adults
age
age distribution
anti-S2
antibody
antibody repertoire
children
circulating
Cohort
contribute
coronavirus
Course
COVID-19 patient
COVID-19 patients
COVID-19 susceptibility
Critical
cross-protection
cross-react
de novo
detectable
distinguishing
distribution
Donor
exhibited
explain
flow cytometry
HCoV
HCoVs
Human
human coronavirus
humans
Humoral immunity
IgA
IgA antibodies
IgG
IgG antibody
IgM
IgM antibodies
IgM antibody
Immunity
Immunoglobulin
Immunoglobulin G
Immunological memory
in some
individual
individuals
Infection
infection rate
memory
much higher
Neutralizing activity
Neutralizing antibodies
Novel coronavirus
novel coronaviruses
observation period
Patient
Perspective
positive
Preexisting immunity
prevalent
proportion
recognizing
respiratory
S1 and S2
S2 subunit
SARS-CoV-2
SARS-COV-2 infection
SARS-CoV-2 neutralizing antibodies
SARS-CoV-2 neutralizing antibody
SARS-CoV-2 proteins
SARS-CoV-2 S
SARS-CoV-2 spike glycoprotein
SARS-CoV-2 spike protein
Science
sera
severe acute respiratory syndrome Coronavirus
spike glycoprotein
Spike protein
subunits
susceptibility
the SARS-CoV-2
uninfected
Wilson
Zoonotic introduction
[DOI] 10.1126/science.abe1107 PMC 바로가기 [Article Type] Report
[DOI] 10.1126/science.abe1107 PMC 바로가기 [Article Type] Report